絞り込み

17706

広告

「Blood Adv[Journal]」の検索結果

1573件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma.

Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity.

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.

Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma.

Ischemic stroke in patients with POEMS syndrome.

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant.

High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.

OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancer.

C/EBPβ isoforms sequentially regulate regenerating mouse hematopoietic stem/progenitor cells.

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression.

Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.

Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients.

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります